检索结果 - Dac M. Dinh

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

    PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models 由 Helen Y. Zou, Luc Friboulet, David P. Kodack, Lars D. Engstrom, Qiuhua Li, Melissa West, Ruth W. Tang, Hui Wang, Konstantinos Tsaparikos, Jinwei Wang, Sergei Timofeevski, Ryohei Katayama, Dac M. Dinh, Hieu Lam, Justine L. Lam, Shinji Yamazaki, Wenyue Hu, Bhushankumar Patel, Divya Bezwada, Rosa L. Frias, Eugene Lifshits, Sidra Mahmood, Justin F. Gainor, Timothy Affolter, Patrick B. Lappin, Hovhannes J. Gukasyan, Nathan Lee, Shibing Deng, Rakesh K. Jain, Ted W. Johnson, Alice T. Shaw, Valeria R. Fantin, Tod Smeal

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib

    Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib 由 Qinhua Huang, Ted W. Johnson, Simon Bailey, Alexei Brooun, Kevin D. Bunker, Benjamin J. Burke, Michael R. Collins, Andrew S. Cook, J. Jean Cui, Kevin N. Dack, Judith G. Deal, Ya‐Li Deng, Dac M. Dinh, Lars D. Engstrom, Mingying He, Jacqui Hoffman, Robert L. Hoffman, Patrick S. Johnson, Robert S. Kania, Hieu Lam, Justine L. Lam, Phuong T. Le, Qiuhua Li, Laura Lingardo, Wei Liu, Melissa West Lu, Michele McTigue, Cynthia L. Palmer, Paul Richardson, Neal W. Sach, Hong Shen, Tod Smeal, Graham L. Smith, Albert Stewart, Sergei Timofeevski, Konstantinos Tsaparikos, Hui Wang, Huichun Zhu, JinJiang Zhu, Helen Y. Zou, Martin P. Edwards

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (<i>R</i>)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (PF-06821497)

    Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (<i>R</... 由 Pei‐Pei Kung, Patrick Bingham, Alexei Brooun, Michael R. Collins, Ya‐Li Deng, Dac M. Dinh, Connie Fan, K.S. Gajiwala, Rita Grantner, Hovhannes J. Gukasyan, Wenyue Hu, Buwen Huang, Robert S. Kania, Susan E. Kephart, Cody Krivacic, Robert A. Kumpf, Penney Khamphavong, Manfred Kraus, Wei Liu, Karen A. Maegley, Lisa Nguyen, Shijian Ren, Dan Richter, Robert A. Rollins, Neal W. Sach, Shikhar Sharma, John Sherrill, Jillian E. Spangler, Albert Stewart, Scott C. Sutton, Sean Uryu, Dominique Verhelle, Hui Wang, Shuiwang Wang, Martin Wythes, Shuibo Xin, Shinji Yamazaki, Huichun Zhu, JinJiang Zhu, Luke R. Zehnder, Martin P. Edwards

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: